{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-049979","form_type":"8-K","ticker":"AVTX","cik":"0001534120","company_name":"Avalo Therapeutics, Inc.","filed_at":"2024-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.719666+00:00","generated_at":"2026-05-29T07:14:39.956766+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Avalo Therapeutics posts updated investor presentation; no material new details available","bullets":["Avalo Therapeutics posted an updated investor presentation on its website on December 5, 2024.","The presentation is intended for use in meetings with investors; no specific financial or operational updates disclosed in the filing.","No earnings, guidance, or material events were reported; the filing is a routine business update."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-049979","json":"https://secwatch.observer/filing/0001628280-24-049979.json","markdown":"https://secwatch.observer/filing/0001628280-24-049979.md","text":"https://secwatch.observer/filing/0001628280-24-049979.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534120/000162828024049979/0001628280-24-049979-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534120/000162828024049979/avtx-20241205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T07:14:39.956766+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}